PHIO Q4 2020 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$45,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-46.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$26,000

Balance Sheet

Total Assets

$16M

Total Liabilities

$3M

Stockholders' Equity

$13M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$45,000	-$16,000	-181.3%
Operating Income	-$2M	-$3M	+7.8%
Net Income	-$2M	-$3M	+7.4%